Business
Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea
BOULDER, CO / ACCESSWIRE / January 31, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented
About this update from Sonoma Pharmaceuticals, Inc.
[{"type":"text","content":"BOULDER, CO / ACCESSWIRE / January 31, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including dermatology, eye, oral and nasal care, and wound care, today announced that it has entered into a distribution agreement with Daewoong Pharmaceutical Co., Ltd. for the marketing and distribution of PrimocynTM Skin Solution products in South Korea.Daewoong Pharmaceutical is one of the largest pharmaceutical companies in South Korea, generating over $1 billion in revenues annually. Pursuant to the distribution agreement, Daewoong Pharmaceutical will have the exclusive right to market, sell and distribute Primocyn Skin Solution products, containing Sonoma's Microcyn technology, in South Korea.\"We believe Primocyn Skin Solution, manufactured by Sonoma Pharmaceuticals, will provide healing and relief to our customers, and will complement our existing line of skin care and healthcare products. We are pleased to be partnering with Sonoma as the distributor for these products in South Korea,\" said Chris Baik, Business Development and Pharmacist, for Daewoong Pharmaceutical.\"Daewoong Pharmaceutical is a leader in the pharmaceutical industry with significant knowledge of the healthcare and skin care markets in South Korea. Our Microcyn-powered Primocyn products have been sold in South Korea for years, and we look forward to this new partnership with Daewoong Pharmaceutical to open up new sales channels and increase sales of Primocyn in South Korea,\" said Amy Trombly, CEO of Sonoma Pharmaceuticals.About Daewoong Pharmaceutical Co., Ltd.Since its establishment in 1945, Daewoong Pharmaceutical has grown to become one of the largest pharmaceutical companies in South Korea. With its strong and competent in-house R&D and cGMP qualified manufacturing facilities, Daewoong Pharmaceutical provides a total healthcare solution to patients across the globe. Daewoong Pharmaceutical offers products in therapeutic areas, such as endocrinology, central nervous system, musculoskeletal, nephrology, antineoplastic, cardiovascular, and other diseases. More information about Daewoong Pharmaceutical can be found at https://www.daewoong.co.kr/.About Sonoma Pharmaceuticals, Inc.Sonoma Pharmaceutic...